GILDER GAGNON HOWE & CO LLC 13D/13G Filings for Flexion Therapeutics, Inc. (FLXN)

GILDER GAGNON HOWE & CO LLC 13D and 13G filings for Flexion Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-02-14
10:19 am
Sale
2019-12-3113GFlexion Therapeutics, Inc.
FLXN
GILDER GAGNON HOWE & CO LLC429,255
1.120%
-1,960,705decrease
(-82.04%)
Filing